Mohammed A. Elbahloul: Every Minute Counts in STEMI Revascularization
Mohammed A. Elbahloul, Guest Editor at Plos One, shared a post on LinkedIn about a recent article he and her colleagues co-authored, published in Cardiovascular Interventions logo Journal, adding:
”I’m pleased to share that our manuscript, ‘Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials,’ has been published in Circulation: Cardiovascular Interventions (IF: 7.4).
I would like to express my sincere gratitude to my co-authors and mentors for their invaluable contributions and support throughout this work.
Key Findings:
- Primary Outcome: In hemodynamically stable patients with STEMI and multivessel disease, an immediate complete revascularization (ICR) strategy may be associated with an increased risk of short-term cardiac death compared with staged complete revascularization (SCR).
- Mortality Trends: Based on the current evidence, a potential increase in both early and late all-cause mortality with ICR cannot be excluded.
- Secondary Endpoints: No significant differences were observed between ICR and SCR in myocardial infarction, repeat revascularization, stent thrombosis, stroke, or major bleeding.
- Clinical Implications: While some uncertainty remains, these findings support a staged complete revascularization strategy for most patients with STEMI and multivessel disease.”
Title: Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials
Authors: Mohammed A. Elbahloul, Shrouk Ramadan, Eman E. Labeeb, Shahed Aldalahmeh, Ahella Ismail A. Mousa, Ahmed Elazab, Ahmed N. Mohamed, Ahmad Elashery, Mehiar O. El-Hamdani, Carl J. Lavie, Gregg W. Stone

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments